Peter Haytaian's most recent trade in Elevance Health Inc was a trade of 11,549 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Elevance Health | Peter D. Haytaian | EVP & Pres Carelon & CarelonRx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 11,549 | 11,549 | - | - | Employee Stock Option (Right to Buy) | |
| Elevance Health | Peter D. Haytaian | EVP & Pres Carelon & CarelonRx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 4,213 | 26,004 (0%) | 0% | 0 | Common Stock | |
| Elevance Health | Peter D. Haytaian | EVP & Pres Carelon & CarelonRx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 3,035 | 21,791 (0%) | 0% | 0 | Common Stock | |
| Elevance Health | Peter D. Haytaian | EVP & Pres Carelon & CarelonRx | Payment of exercise price or tax liability using portion of securities received from the company at price $ 395.50 per share. | 03 Mar 2025 | 2,281 | 18,756 (0%) | 0% | 395.5 | 902,136 | Common Stock |
| Elevance Health | Peter D. Haytaian | EVP & Pres Carelon & CarelonRx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2024 | 3,799 | 21,037 (0%) | 0% | 0 | Common Stock | |
| Elevance Health | Peter D. Haytaian | EVP & Pres Carelon & CarelonRx | Payment of exercise price or tax liability using portion of securities received from the company at price $ 414.01 per share. | 01 Nov 2024 | 1,649 | 17,238 (0%) | 0% | 414.0 | 682,702 | Common Stock |
| Elevance Health | Peter Haytaian D. | EVP & Pres Carelon & CarelonRx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 166.97 per share. | 01 Mar 2024 | 15,000 | 39,982 (0%) | 0% | 167.0 | 2,504,550 | Common Stock |
| Elevance Health | Peter Haytaian D. | EVP & Pres Carelon & CarelonRx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 15,000 | 4,908 | - | - | Employee Stock Option (Right to Buy) | |
| Elevance Health | Peter Haytaian D. | EVP & Pres Carelon & CarelonRx | Sale of securities on an exchange or to another person at price $ 500.18 per share. | 01 Mar 2024 | 15,000 | 18,887 (0%) | 0% | 500.2 | 7,502,700 | Common Stock |
| Elevance Health | Peter Haytaian D. | EVP & Pres Carelon & CarelonRx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 9,280 | 9,280 | - | - | Employee Stock Option (Right to Buy) | |
| Elevance Health | Peter Haytaian D. | EVP & Pres Carelon & CarelonRx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 9,152 | 24,982 (0%) | 0% | 0 | Common Stock | |
| Elevance Health | Peter Haytaian D. | EVP & Pres Carelon & CarelonRx | Payment of exercise price or tax liability using portion of securities received from the company at price $ 499.11 per share. | 01 Mar 2024 | 4,314 | 13,425 (0%) | 0% | 499.1 | 2,153,161 | Common Stock |
| Elevance Health | Peter Haytaian D. | EVP & Pres Carelon & CarelonRx | Sale of securities on an exchange or to another person at price $ 500.18 per share. | 01 Mar 2024 | 4,206 | 35,776 (0%) | 0% | 500.2 | 2,103,757 | Common Stock |
| Elevance Health | Peter Haytaian D. | EVP & Pres Carelon & CarelonRx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 2,405 | 15,830 (0%) | 0% | 0 | Common Stock | |
| Elevance Health | Peter Haytaian D. | EVP & Pres Carelon & CarelonRx | Sale of securities on an exchange or to another person at price $ 500.18 per share. | 01 Mar 2024 | 1,889 | 33,887 (0%) | 0% | 500.2 | 944,840 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & Pres Carelon & CarelonRx | Payment of exercise price or tax liability using portion of securities received from the company at price $ 446.66 per share. | 01 Nov 2023 | 154 | 17,739 (0%) | 0% | 446.7 | 68,786 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & Pres Carelon & CarelonRx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 9,716 | 23,362 (0%) | 0% | 0 | Common Stock | |
| Elevance Health | Peter Haytaian | EVP & Pres Carelon & CarelonRx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 8,812 | 8,812 | - | - | Employee Stock Option (Right to Buy) | |
| Elevance Health | Peter Haytaian | EVP & Pres Carelon & CarelonRx | Payment of exercise price or tax liability using portion of securities received from the company at price $ 468.78 per share. | 01 Mar 2023 | 5,469 | 17,893 (0%) | 0% | 468.8 | 2,563,758 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & Pres Carelon & CarelonRx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 2,292 | 13,646 (0%) | 0% | 0 | Common Stock | |
| Elevance Health | Peter Haytaian | EVP & Pres Carelon & CarelonRx | Payment of exercise price or tax liability using portion of securities received from the company at price $ 469.03 per share. | 01 Mar 2023 | 607 | 11,354 (0%) | 0% | 469.0 | 284,701 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & Pres Carelon & IngenioRx | Payment of exercise price or tax liability using portion of securities received from the company at price $ 544.53 per share. | 01 Nov 2022 | 200 | 11,961 (0%) | 0% | 544.5 | 108,906 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & Pres., DBG & IngenioRx | Sale of securities on an exchange or to another person at price $ 461.72 per share. | 10 Mar 2022 | 5,874 | 13,441 (0%) | 0% | 461.7 | 2,712,143 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & Pres., DBG & IngenioRx | Sale of securities on an exchange or to another person at price $ 459.75 per share. | 10 Mar 2022 | 4,274 | 23,420 (0%) | 0% | 459.8 | 1,964,972 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & Pres., DBG & IngenioRx | Sale of securities on an exchange or to another person at price $ 460.68 per share. | 10 Mar 2022 | 4,105 | 19,315 (0%) | 0% | 460.7 | 1,891,091 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & Pres., DBG & IngenioRx | Sale of securities on an exchange or to another person at price $ 458.68 per share. | 10 Mar 2022 | 2,170 | 27,694 (0%) | 0% | 458.7 | 995,336 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & Pres., DBG & IngenioRx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2022 | 1,848 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Elevance Health | Peter Haytaian | EVP & Pres., DBG & IngenioRx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 131.80 per share. | 10 Mar 2022 | 1,848 | 29,864 (0%) | 0% | 131.8 | 243,566 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & Pres., DBG & IngenioRx | Sale of securities on an exchange or to another person at price $ 462.73 per share. | 10 Mar 2022 | 1,240 | 12,201 (0%) | 0% | 462.7 | 573,785 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & Pres., DBG & IngenioRx | Sale of securities on an exchange or to another person at price $ 463.40 per share. | 10 Mar 2022 | 40 | 12,161 (0%) | 0% | 463.4 | 18,536 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & Pres., DBG & IngenioRx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 8,832 | 8,832 | - | - | Employee Stock Option (Right to Buy) | |
| Elevance Health | Peter Haytaian | EVP & Pres., DBG & IngenioRx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 8,250 | 28,509 (0%) | 0% | 0 | Common Stock | |
| Elevance Health | Peter Haytaian | EVP & Pres., DBG & IngenioRx | Payment of exercise price or tax liability using portion of securities received from the company at price $ 451.50 per share. | 01 Mar 2022 | 4,667 | 18,044 (0%) | 0% | 451.5 | 2,107,151 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & Pres., DBG & IngenioRx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 2,215 | 20,259 (0%) | 0% | 0 | Common Stock | |
| Elevance Health | Peter Haytaian | EVP & Pres., DBG & IngenioRx | Payment of exercise price or tax liability using portion of securities received from the company at price $ 463.49 per share. | 01 Mar 2022 | 493 | 28,016 (0%) | 0% | 463.5 | 228,501 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 349.53 per share. | 22 Mar 2021 | 26,777 | 33,164 (0%) | 0% | 349.5 | 9,359,365 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 131.80 per share. | 22 Mar 2021 | 22,500 | 82,044 (0%) | 0% | 131.8 | 2,965,500 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Mar 2021 | 22,500 | 1,848 | - | - | Employee Stock Option (Right to Buy) | |
| Elevance Health | Peter Haytaian | EVP & President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.93 per share. | 22 Mar 2021 | 15,593 | 59,544 (0%) | 0% | 146.9 | 2,291,079 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Mar 2021 | 15,593 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Elevance Health | Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 348.52 per share. | 22 Mar 2021 | 12,416 | 59,941 (0%) | 0% | 348.5 | 4,327,224 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 347.44 per share. | 22 Mar 2021 | 9,387 | 72,357 (0%) | 0% | 347.4 | 3,261,419 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 350.21 per share. | 22 Mar 2021 | 7,891 | 25,273 (0%) | 0% | 350.2 | 2,763,507 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 352.84 per share. | 22 Mar 2021 | 2,329 | 22,544 (0%) | 0% | 352.8 | 821,764 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 351.32 per share. | 22 Mar 2021 | 400 | 24,873 (0%) | 0% | 351.3 | 140,528 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 345.59 per share. | 22 Mar 2021 | 300 | 81,744 (0%) | 0% | 345.6 | 103,677 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & President, Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 23,222 | 44,443 (0%) | 0% | 0 | Common Stock | |
| Elevance Health | Peter Haytaian | EVP & President, Commercial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 311.48 per share. | 01 Mar 2021 | 14,231 | 18,411 (0%) | 0% | 311.5 | 4,432,672 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & President, Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 11,533 | 11,533 | - | - | Employee Stock Option (Right to Buy) | |
| Elevance Health | Peter Haytaian | EVP & President, Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 2,810 | 21,221 (0%) | 0% | 0 | Common Stock | |
| Elevance Health | Peter Haytaian | EVP & President, Commercial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 311.66 per share. | 01 Mar 2021 | 492 | 43,951 (0%) | 0% | 311.7 | 153,337 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.93 per share. | 15 Dec 2020 | 5,833 | 38,475 (0%) | 0% | 146.9 | 857,043 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2020 | 5,833 | 15,593 | - | - | Employee Stock Option (Right to Buy) | |
| Elevance Health | Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 312.76 per share. | 15 Dec 2020 | 3,836 | 32,742 (0%) | 0% | 312.8 | 1,199,747 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 312.01 per share. | 15 Dec 2020 | 1,897 | 36,578 (0%) | 0% | 312.0 | 591,883 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 313.42 per share. | 15 Dec 2020 | 100 | 32,642 (0%) | 0% | 313.4 | 31,342 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 333.97 per share. | 16 Nov 2020 | 1,200 | 34,810 (0%) | 0% | 334.0 | 400,764 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 334.87 per share. | 16 Nov 2020 | 1,193 | 33,617 (0%) | 0% | 334.9 | 399,500 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 332.86 per share. | 16 Nov 2020 | 1,056 | 36,010 (0%) | 0% | 332.9 | 351,500 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 330.77 per share. | 16 Nov 2020 | 1,010 | 37,466 (0%) | 0% | 330.8 | 334,078 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.93 per share. | 16 Nov 2020 | 927 | 38,476 (0%) | 0% | 146.9 | 136,204 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2020 | 927 | 21,426 | - | - | Employee Stock Option (Right to Buy) | |
| Elevance Health | Peter Haytaian | EVP & President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 100.77 per share. | 16 Nov 2020 | 781 | 37,549 (0%) | 0% | 100.8 | 78,701 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2020 | 781 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Elevance Health | Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 335.92 per share. | 16 Nov 2020 | 675 | 32,942 (0%) | 0% | 335.9 | 226,746 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 331.92 per share. | 16 Nov 2020 | 400 | 37,066 (0%) | 0% | 331.9 | 132,768 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 337.00 per share. | 16 Nov 2020 | 300 | 32,642 (0%) | 0% | 337 | 101,100 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2020 | 4,667 | 781 | - | - | Employee Stock Option (Right to Buy) | |
| Elevance Health | Peter Haytaian | EVP & President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 100.77 per share. | 15 Oct 2020 | 4,667 | 42,602 (0%) | 0% | 100.8 | 470,294 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 292.13 per share. | 15 Oct 2020 | 1,600 | 39,202 (0%) | 0% | 292.1 | 467,408 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 295.00 per share. | 15 Oct 2020 | 1,167 | 36,768 (0%) | 0% | 295 | 344,265 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 293.33 per share. | 15 Oct 2020 | 1,120 | 38,082 (0%) | 0% | 293.3 | 328,530 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 287.58 per share. | 15 Oct 2020 | 1,000 | 41,602 (0%) | 0% | 287.6 | 287,580 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 290.30 per share. | 15 Oct 2020 | 800 | 40,802 (0%) | 0% | 290.3 | 232,240 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 293.98 per share. | 15 Oct 2020 | 147 | 37,935 (0%) | 0% | 294.0 | 43,215 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 295.00 per share. | 09 Oct 2020 | 1,167 | 37,935 (0%) | 0% | 295 | 344,265 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & President, Commercial | Sale of securities on an exchange or to another person at price $ 280.00 per share. | 02 Oct 2020 | 4,667 | 39,102 (0%) | 0% | 280 | 1,306,760 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Oct 2020 | 2,592 | 5,448 | - | - | Employee Stock Option (Right to Buy) | |
| Elevance Health | Peter Haytaian | EVP & President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 100.77 per share. | 02 Oct 2020 | 2,592 | 43,769 (0%) | 0% | 100.8 | 261,196 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.44 per share. | 02 Oct 2020 | 2,075 | 41,177 (0%) | 0% | 89.4 | 185,588 | Common Stock |
| Elevance Health | Peter Haytaian | EVP & President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Oct 2020 | 2,075 | 0 | - | - | Employee Stock Option (Right to Buy) |